Fecal ESBL Resurgence During Antibiotic Treatment

University Hospital, Akershus

Status

Terminated

Conditions

Antibiotic Drug Resistance

Study type

Observational

Funder types

Other

Identifiers

NCT03206879

16-086

Details and patient eligibility

About

Norwegian hospitals are struggling to control spread of extended-spectrum beta-lactamase producing Enterobacteriaceae (ESBL-E) in health care settings. Strict screening and isolation criteria are enforced in hospital, and patients previously infected by ESBL-E are regarded as possible ESBL-E carriers indefinitely. This observational multi-centre cross-sectional study aims to estimate the duration of fecal ESBL-E carriage and to assess the risk of ESBL-E resurgence during hospital stay for patients previously infected by ESBL-E. Through better knowledge of these risk factors, infection control procedures may be better tailored to rhe individual patient.

Enrollment

50 patients

Sex

All

Ages

18 to 120 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Patients with previous infection or colonization with ESBL-E admitted to one of the participating wards. -

Exclusion criteria